|royalty pharma fda||0.3||0.3||3704||34|
The quality and scale of Royalty Pharma’s portfolio of pharmaceutical royalties is unparalleled in the industry. Since 1996, we have meticulously acquired royalty interests in many of the industry’s leading drugs by sales addressing serious unmet medical needs.How do I contact Royalty Pharma?
110 E 59th Street FL 33 New York, NY 10022 +1 (212) 883-0200 [email protected] Social icons Legal Nav TERMSPRIVACYWhat is approved product royalty monetization?
APPROVED PRODUCT ROYALTY MONETIZATION The biopharmaceutical industry is undergoing a period of strong growth and unprecedented innovation. We intend to further this innovation by acquiring royalties on leading biopharmaceutical products. lnk Royalty Monetization